Company Badge
USPTO Data Jan 1 1976 - Oct 27 2026
7 Patents
#36 in Plymouth, MI
#1,363 in Michigan
#39,950 in US
Pronai Therapeutics, Inc.
Forward Citations = 52
12 inventors:
Plymouth, MI, United States of America
Pronai Therapeutics, Inc.
Calculating rank
% Expired Patents = 71.4
EPO Patents = 3
Trademarks = 1
Forward Citations = 52
Loading Chart...
Loading Chart...
12 inventors (with patents filed for the assignee):
Neal Goodwin (7 out of 7 patents)
David Olson (5 out of 9 patents)
Mina Patel Sooch (4 out of 4 patents)
4. Gholamreza Sheikhnehjad (3 out of 3 patents)
5. Steffen Panzner (1 out of 21 patents)
6. Natalie Herzog (1 out of 2 patents)
7. Yvonne Kerwitz (1 out of 4 patents)
8. Gerold Endert (1 out of 12 patents)
9. James Patrick McGovren (1 out of 1 patent)
10. Wendi Rodrigueza (1 out of 2 patents)
11. Gholamreza Sheikhnejad (1 out of 1 patent)
12. Reza Sheikhnejad (1 out of 1 patent)
13. Neal Clifford Goodwin (0 patent)
14. James Patrick Mc Govren (0 patent)
7 patents:
Company Overview
Pronai Therapeutics, Inc. is a clinical stage biopharmaceutical company focused on developing novel small molecule therapeutic agents for the treatment of cancer and autoimmune diseases. The company's lead compound, PNT2258, has shown promising results in preclinical studies and is currently undergoing clinical trials. Pronai Therapeutics aims to address unmet medical needs by developing innovative therapies that target key pathways involved in disease progression.
Profile summary synthesized from public USPTO records and patent filings.
IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Pronai Therapeutics, Inc.. Retrieved from https://idiyas.com/company/pronai-therapeutics
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
3 patents (EPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]